MICROORGANISM COMPRISING GENETIC MODIFICATION THAT INCREASES ACTIVITY OF MULTIDRUG TRANSPORTER, AND METHOD FOR PRODUCING TRYPTOPHAN METABOLITES BY USING SAME
Disclosed is a recombinant microorganism comprising a genetic modification that increases the activity of a multidrug transporter A (multidrug efflux system subunit A: MdtA). A recombinant microorganism comprising genetic modification that increases the activity of a multidrug transporter and a meth...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
24.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed is a recombinant microorganism comprising a genetic modification that increases the activity of a multidrug transporter A (multidrug efflux system subunit A: MdtA). A recombinant microorganism comprising genetic modification that increases the activity of a multidrug transporter and a method for producing tryptophan metabolites by using same enable mass-production of tryptophan metabolites.
L'invention concerne un micro-organisme recombinant comprenant une modification génétique qui augmente l'activité d'un transporteur de médicaments multiples A (sous-unité A de système d'efflux de médicaments multiples : MdtA). Un micro-organisme recombinant comprenant une modification génétique qui augmente l'activité d'un transporteur de médicaments multiples et un procédé de production de métabolites de tryptophane à l'aide de celui-ci permettent la production en masse de métabolites de tryptophane.
다중약물 수송체 A(Multidrug efflux system subunit A: MdtA)의 활성을 증가시키는 유전적 변형(genetic modification)을 포함하는 재조합 미생물에 관한 것이다. 다중약물 수송체의 활성을 증가시키는 유전적 변형을 포함하는 재조합 미생물, 및 그를 이용한 트립토판 대사체를 생산하는 방법은 트립토판 대사체의 대량 생산을 가능하게 할 수 있다. |
---|---|
Bibliography: | Application Number: WO2020KR11315 |